Use your antibodies-online credentials, if available.
抗Human P2RY6 抗体:
抗Mouse (Murine) P2RY6 抗体:
抗Rat (Rattus) P2RY6 抗体:
Expression levels of P2Y6 receptor were higher in Parkinson's disease patients compared to healthy controls.
These data suggest that, without infection, inactivated-H5N1 induces mRNA expression of IL-6 (显示 IL6 抗体) and CXCL8 (显示 IL8 抗体) by a mechanism, or mechanisms, requiring interaction between viral hemagglutinin (显示 HA 抗体) and alpha-2,3 sialic acid receptors at the cell membrane of host cells, and involves activation of P2Y6 purinergic receptors.
Rescuing miR (显示 MLXIP 抗体)-185 expression to inhibit P2Y6 may represent a therapeutic strategy against human aortic vascular smooth muscle cells dysfunction and hypertension.
data demonstrate that HNP-1 induces IL-8 production not only through P2Y6, but also through additional P2 receptors via an ERK1/2-dependent mechanism in intestinal epithelial cells.
nucleotides released during the airway inflammatory processes will activate P2Y6 receptors, which will lead to further release of inflammatory cytokines.
high millimolar concentrations of ATP increased IL-8 (显示 IL8 抗体) and MCP-1 (显示 CCL2 抗体) release by the glioma cells stimulated with suboptimal LPS (显示 IRF6 抗体) concentration which were blocked by P2X7 (显示 P2RX7 抗体) and P2Y6 antagonists
Data indicate that after P2Y6 receptor stimulation both phospholipase D (PLD (显示 PLD 抗体)) and DGKzeta (显示 DGKZ 抗体) enzymes are responsible for producing phosphatidic acid (PA).
Using rat P2Y6 recombinant protein expressed in human astrocytoma cells, the authors found that the P2Y6 receptor is highly selective for UDP over UTP.
Results indicate involvement of P2Y purinoceptors P2Y(1) and P2Y(6) receptors in ADP- and UDP-stimulated proliferation.
no obvious correlation was found between the expression of P2Y6 and breast cancer cell proliferation
these findings suggest that the P2Y6 receptor plays a critical role in mediating microglial phagocytosis in radiation-induced brain injury.
P2Y6 UDP receptor, the most expressed P2Y (显示 P2RY1 抗体) receptor in mouse resistance arteries, is required for maintaining proper arterial tone.
The present study identifies mouse P2Y6 receptor as a regulator of cardiac development and cardiomyocyte function. P2Y6 receptor could constitute a therapeutic target to regulate cardiac hypertrophy.
These results suggest that increased formation of AT1R (显示 AGTRAP 抗体)-P2Y6R heterodimers with age may increase the likelihood of hypertension induced by Ang II (显示 AGT 抗体).
Study demonstrates that AgRP (显示 AGRP 抗体) neurons express the purinergic receptor (显示 P2RX7 抗体) 6 (P2Y6), which is activated by uridine-diphosphate (UDP). In vivo, UDP induces ERK (显示 EPHB2 抗体) phosphorylation and cFos expression in AgRP (显示 AGRP 抗体) neurons and promotes action potential firing of these neurons in brain slice recordings.
P2Y (显示 P2RY1 抗体)(6) receptor augments pro-inflammatory responses in macrophages
The results demonstrate the important role of P2Y6 as a danger signal in antiviral immune responses.
these data outline a novel role for the P2Y6 receptor in the induction of CXCL8/IL-8 (显示 IL8 抗体) production and barrier dysfunction in response to C. difficile toxin exposure and may provide a new therapeutic target for the treatment of CDI.
P2Y6 deficiency limits atherosclerosis and plaque inflammation in mice.
P2Y (显示 P2RY1 抗体)(6) receptor signaling pathway may be a potential therapeutic target for MSU (显示 BCKDHA 抗体)-associated inflammatory diseases, such as tophaceous gout.
The product of this gene belongs to the family of P2 receptors, which is activated by extracellular nucleotides and subdivided into P2X ligand-gated ion channels and P2Y G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor, which is a G-protein coupled receptor, is responsive to UDP, partially responsive to UTP and ADP, and not responsive to ATP. It is proposed that this receptor mediates inflammatory responses. Alternative splicing results in multiple transcript variants that encode different protein isoforms.
G-coupled nucleotide receptor
, P2 purinoceptor
, P2Y purinoceptor 6
, P2Y6 receptor
, P2Y ATP receptor 6
, G protein-coupled P2 receptor
, P2Y purinoceptor 3
, nucleoside diphosphate receptor
, P2Y6 nucleotide receptor
, pyrimidinergic receptor P2Y6